Sugar Derivatives TRIZ Cases

A base-labile protecting group strategy for ribose 2-hydroxyls enables efficient chemical RNA synthesis without linker rupture.

Microwave irradiation extracts pectin and limonene from citrus waste without acidic pre-treatment.

A multiplex polymerase chain reaction amplifies multiple CFTR gene segments in a single vessel using specific oligonucleotide primer pairs.

Modular scaffold-glycoconjugate constructs resolve stability and selectivity contradictions in Shiga toxin diagnostics.

Xylose derivatives replace toxic polar aprotic solvents, maintaining solubilizing properties while eliminating reproductive hazards.

Targeting Helios expression in CD4+CD25+ T cells resolves the contradiction between regulating suppressive activity and maintaining immune response efficacy.

RFC40 inhibition targets DNA replication to treat triple-negative breast cancer lacking standard receptors.

Degenerate primer amplification normalizes small nucleic acid populations, overcoming cloning biases that distort low-abundance species representation.

Recombinant plasmids deliver MhPDR1 and MhPDR2 genes to banana plants, resolving the contradiction between high yield and physiological stress susceptibility.

A sequential lysis protocol extracts nucleic acids from diverse microbial populations using detergent, lysozyme, and chaotropic agents.

A nucleoside derivative incorporates purine and pyrimidine rings to boost target affinity in polynucleotide synthesis.

Palladium-catalyzed synthesis of modified cytidine nucleotides improves aptamer target affinity and nuclease stability during SELEX selection.

Milk-derived microvesicles encapsulate therapeutic agents via sequential centrifugation, resolving toxicity constraints while improving solubility.

A one-pot stereoselective process synthesizes C-aryl glucosides using acid labile protecting groups to minimize intermediate production.

Oligonucleotide primers with 5' extensions enable universal amplification of conserved ribosomal DNA regions.

Crystallization of stevioside M into form A overcomes production cost and purity trade-offs by using specific solvent systems to achieve superior stability.

Segmenting diagnostic protocols to identify specific ZFYVE26 mutations resolves delayed AR-HSP identification while maintaining comprehensive genetic coverage.

Primer and probe sets target conserved intergenic regions between ORF1, ORF2, and ORF3 to resolve limited coverage of conventional detection methods.

Engineered fluorescent proteins use exterior positive charges to permeate cells without transfection.

A PLVAP antagonist antibody targets the Plasmalemma Vesicle-Associated Protein to inhibit tumor growth in hepatocellular carcinoma.

A multiplex real-time PCR assay uses specific gene probes to identify methicillin-resistant Staphylococcus aureus and related species.

A modified plasmid vector uses replication protein substitutions to increase extracellular secretion of target proteins.

Anti-miRNA-binding proteins isolate miRNAs from biofluids via immunoprecipitation, eliminating toxic compounds and spin columns.

Optimized temperature and solvent parameters resolve the contradiction between simple production and high purity, enabling scalable floxuridine synthesis.

A tricyclic cytidine compound boosts fluorescence quantum yield twenty-fold upon DNA duplex formation.

Detects ATM gene mRNA variants from non-canonical splicing to assess glucocorticoid response, avoiding unnecessary therapy and minimizing steroid toxicity.

Specific reactive groups on novel rhodamine dyes enhance polymerase incorporation efficiency, reducing cumulative product loss during nucleic acid synthesis.

Identified promiscuous HER-2/Neu epitopes overcome HLA-restriction limits, enabling universal cancer immunotherapy applicability.

Specific CYBA untranslated regions flank coding sequences to boost protein expression levels in engineered RNA molecules.

Segmented destabilizing oligonucleotides prevent pseudogene amplification and resolve variable cycle threshold cutoffs in PIK3CA mutation detection.

Soaking fired zeolite bodies in transition metal oxide solutions eliminates washcoating layers, reducing exhaust backpressure while maintaining NOx reduction.

Targeted nuclease injection into sperm establishes heritable traits in one generation, eliminating the need to screen hundreds of birds.

Site-directed mutagenesis creates BChE mutants that increase cocaine hydrolysis efficiency by over one hundred-fold, addressing limited wild-type activity.

Activated carbon adsorbs furan derivatives from reaction mixtures, enabling efficient separation via solvent-based desorption.

A microRNA-based classifier identifies tumor tissue origin using specific expression profiles.

Segmented genetic analysis of REEP1 mutations differentiates hereditary spastic paraplegia variants without complex whole-genome sequencing.

Universal adaptor oligonucleotides hybridize with nucleic acid strands and identifiers to streamline encoding, reducing the number of required oligonucleotides.

MicroRNA expression profiles identify specific markers to differentiate B cell malignancies, resolving diagnostic ambiguity from overlapping morphologies.

Engineered chimeric ta-siRNA sequences target specific plant genes through complementary base pairing to achieve precise molecular silencing.

Soy oligosaccharides undergo selective hydrolysis to release galactose, which is then converted into tagatose through enzymatic isomerization.

Compounds of Formula V to XI exhibit preferential toxicity towards malignant cells while maintaining selectivity for normal lymphocytes.

Near-infrared excited upconverting nanoparticles paired with aptamer-quenchers attenuate signals via LRET, eliminating matrix interference in food samples.

Targeting SNPs in UBASH3A, GLIS3, RASGRP1, BACH2, and EDG7 overcomes incomplete genetic understanding to improve T1D diagnosis.

Isomerizing glucose to fructose in an alcoholic medium using a basic catalyst at temperatures above 75°C.

Genotyping SNPs rs4954256 and rs16863886 identifies patients likely to achieve complete response, avoiding toxicity from ineffective chemoradiotherapy.

A nucleic acid probe with a reactive nucleobase derivative transfers a radioactive label to the target strand.